INTERNATIONAL PATENT: BEREN THERAPEUTICS P.B.C. FILES APPLICATION FOR "2-HYDROXYPROPYL BETA-CYCLODEXTRINS FOR USE IN A METHOD OF TREATING NIEMANN-PICK DISEASE TYPE C IN SUBJECTS WITH INFANTILE ONSET"

GENEVA, Feb. 3 -- BEREN THERAPEUTICS P.B.C. (9200 Sunset Blvd Ste 1010West Hollywood, CA 90069) filed a patent application (PCT/IB2025/057566) for "2-HYDROXYPROPYL BETA-CYCLODEXTRINS FOR USE IN A METHOD OF TREATING NIEMANN-PICK DISEASE TYPE C IN SUBJECTS WITH INFANTILE ONSET" on Jul 25, 2025. With publication no. WO/2026/022777, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WINNIKE, Jack (c/o Beren Therapeutics P.B.C.9200 Sunset Blvd Ste 1010West Hollywood, California 90069), JIAO, Lisa (c/o Beren Therapeutics P.B.C.920...